Diane E. Wilfong Gilead Sciences, Inc. (GILD) insider trading activity

Diane E. Wilfong is SVP, Controller & CAO of GILEAD SCIENCES, INC.. Currently has a direct ownership of 32,010 shares of GILD, which is worth approximately $2.47 Million. The most recent transaction as insider was on Feb 06, 2023, when has been sold 565 shares (Common Stock) at a price of $86.36 per share, resulting in proceeds of $48,793. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32K

0% 3M change

0% 12M change

Total Value Held $2.47 Million

Diane E. Wilfong Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 06 2023	SELL Payment of exercise price or tax liability	$48,793 $86.36 p/Share	565 Reduced 1.73%	32,010 Common Stock
Feb 06 2023	BUY Exercise of conversion of derivative security	-	1,864 Added 5.41%	32,575 Common Stock
Jan 24 2023	SELL Payment of exercise price or tax liability	$104,520 $84.02 p/Share	1,244 Reduced 3.89%	30,711 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	-	5,884 Added 15.55%	31,955 Common Stock
Dec 10 2022	SELL Payment of exercise price or tax liability	$13,107 $87.97 p/Share	149 Reduced 0.52%	28,502 Common Stock
Dec 10 2022	BUY Exercise of conversion of derivative security	-	318 Added 1.1%	28,651 Common Stock
Nov 09 2022	SELL Open market or private sale	$535,736 $83.5 p/Share	6,416 Reduced 18.46%	28,333 Common Stock

Nov 09 2022	BUY Exercise of conversion of derivative security	$410,046 $63.91 p/Share	6,416 Added 15.59%	34,749 Common Stock
Nov 01 2022	SELL Open market or private sale	$1,288,208 $79.25 p/Share	16,255 Reduced 36.46%	28,333 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	$1,181,738 $72.7 p/Share	16,255 Added 26.72%	44,588 Common Stock
Sep 10 2022	SELL Payment of exercise price or tax liability	$9,661 $65.28 p/Share	148 Reduced 0.52%	28,333 Common Stock
Sep 10 2022	BUY Exercise of conversion of derivative security	-	318 Added 1.1%	28,481 Common Stock
Aug 10 2022	SELL Payment of exercise price or tax liability	$67,307 $63.14 p/Share	1,066 Reduced 3.65%	28,163 Common Stock
Aug 10 2022	BUY Exercise of conversion of derivative security	-	2,479 Added 7.82%	29,229 Common Stock
Jun 10 2022	SELL Payment of exercise price or tax liability	$8,990 $60.74 p/Share	148 Reduced 0.55%	26,750 Common Stock
Jun 10 2022	BUY Exercise of conversion of derivative security	-	317 Added 1.16%	26,898 Common Stock
Mar 10 2022	SELL Payment of exercise price or tax liability	$54,155 $57.92 p/Share	935 Reduced 3.4%	26,581 Common Stock
Mar 10 2022	BUY Exercise of conversion of derivative security	-	3,297 Added 10.7%	27,516 Common Stock
Feb 06 2022	SELL Payment of exercise price or tax liability	$33,228 $63.9 p/Share	520 Reduced 2.1%	24,219 Common Stock
Feb 06 2022	BUY Exercise of conversion of derivative security	-	1,864 Added 7.01%	24,739 Common Stock
Jan 26 2022	SELL Payment of exercise price or tax liability	$26,532 $67.34 p/Share	394 Reduced 1.69%	22,875 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	2,871 Added 10.98%	23,269 Common Stock
Aug 17 2021	SELL Open market or private sale	$986,725 $72.5 p/Share	13,610 Reduced 40.02%	20,398 Common Stock
Aug 17 2021	BUY Exercise of conversion of derivative security	$919,492 $67.56 p/Share	13,610 Added 28.58%	34,008 Common Stock
Aug 10 2021	SELL Payment of exercise price or tax liability	$62,801 $69.24 p/Share	907 Reduced 4.26%	20,398 Common Stock

Also insider at

IMPL

IMPEL PHARMACEUTICALS INC Healthcare

DEW

Diane E. Wilfong

SVP, Controller & CAO

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account